Skip to main content
Equibles

Invesco Ltd.

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 914208 Atlanta, GA
Back to AMLX Full portfolio

Position in AMLX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,513,357
+$127,840 QoQ
Shares Held
139,942
-18.5% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 207 holders
Holding Since
Sep 2022
13 quarters on record
Voting authority Sole 0% Shared 98% None 2%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $1,945,758,306 across 45 Drug Manufacturers - Specialty & Generic names. AMLX ranks #25 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 5,523,018 $396,884,069
2 VTRS
Viatris Inc
 20,771,275 $329,847,840
3 UTHR
UNITED THERAPEUTICS Corp
 473,109 $256,344,645
4 NBIX
Neurocrine Biosciences Inc
 1,077,317 $181,571,000
5 ELAN
Elanco Animal Health Inc
 5,306,326 $130,588,679
6 TEVA
Teva Pharmaceutical Industries Ltd
 3,430,011 $116,208,767
7 INDV
Indivior Pharmaceuticals, Inc.
 1,842,983 $75,617,590
8 COLL
Collegium Pharmaceutical, Inc
 1,882,499 $68,146,461

All Filings in AMLX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,513,357 139,942
2026-03-31 $2,385,517 171,620
2025-12-31 $2,125,040 175,914
2025-09-30 $11,016,597 810,640
2025-06-30 $3,761,918 586,883
2025-03-31 $161,756 45,694
2024-03-31 $69,150 24,349
2023-12-31 $351,732 23,895
2023-09-30 $546,277 29,835
2023-06-30 $576,780 26,740
2023-03-31 $672,970 22,937
2022-12-31 $7,961,615 215,470
2022-09-30 $7,362,237 261,536